Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
Stock data | 2023 | Change |
---|---|---|
Price | $40.31 | N/A |
Market Cap | $3.34B | N/A |
Shares Outstanding | 82.89M | 0.25% |
Employees | 4.05K | N/A |
Shareholder Equity | 17.00B | 10.10% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 1.40 | N/A |
P/S Ratio | 13.91 | N/A |
P/B Ratio | 0.20 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0017 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $240.26M | N/A |
Earnings | $28.72M | N/A |
EPS | 28.74 | N/A |
Earnings Yield | 0.713 | N/A |
Gross Margin | 0.7783 | N/A |
Operating Margin | 0.3082 | N/A |
Net income margin | 0.1195 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $284.17M | N/A |
Total Debt | $49.97M | N/A |
Cash on Hand | $101.37M | N/A |
Debt to Equity | 0.0048 | -23.05% |
Cash to Debt | $2.03 | 58.45% |
Current Ratio | $2.07 | 18.32% |